Non-Current Assets
Goodwill
Bristol-Myers Squibb Goodwill decreased by 0.1% to $21.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from $21.74B to $21.74B. Over 5 years (FY 2020 to FY 2025), Goodwill shows relatively stable performance with a 1.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Large increases signal recent M&A activity, while sudden decreases often indicate impairment charges due to underperforming acquisitions.
Detailed definition
This asset arises when a company acquires another entity for a price higher than the fair market value of its identifiab...
Peer comparison
Commonly elevated in the pharmaceutical industry due to frequent M&A activity to bolster drug pipelines.
Metric ID:
goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.53B | $20.52B | $20.50B | $20.50B | $20.45B | $21.11B | $21.15B | $21.16B | $21.16B | $21.15B | $21.17B | $21.74B | $21.73B | $21.75B | $21.72B | $21.74B | $21.78B | $21.75B | $21.75B | $21.74B |
| QoQ Change | — | -0.0% | -0.1% | -0.0% | -0.3% | +3.3% | +0.2% | +0.1% | +0.0% | -0.1% | +0.1% | +2.7% | -0.0% | +0.1% | -0.1% | +0.1% | +0.2% | -0.1% | +0.0% | -0.1% |
| YoY Change | — | — | — | — | -0.4% | +2.9% | +3.2% | +3.2% | +3.5% | +0.2% | +0.1% | +2.7% | +2.7% | +2.9% | +2.6% | -0.0% | +0.2% | -0.0% | +0.2% | +0.0% |
Range$20.45B – $21.78B
CAGR+1.2%
Avg YoY Growth+1.5%
Median YoY Growth+1.4%
Goodwill at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's goodwill?
- Bristol-Myers Squibb (BMY) reported goodwill of $21.74B in Q1 2026.
- How has Bristol-Myers Squibb's goodwill changed year-over-year?
- Bristol-Myers Squibb's goodwill increased by 0.0% year-over-year, from $21.74B to $21.74B.
- What is the long-term trend for Bristol-Myers Squibb's goodwill?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's goodwill has grown at a 1.1% compound annual growth rate (CAGR), from $20.55B to $21.75B.
- What does goodwill mean?
- The premium paid over fair value during acquisitions, representing intangible value.